Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CapsoVision, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CV
Nasdaq
3840
capsovision.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CapsoVision, Inc.
CapsoVision to Participate in Upcoming Investor Conferences
- Sep 3rd, 2026 2:05 pm
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ...
- Aug 13th, 2026 11:01 pm
CapsoVision Q2 Earnings Call Highlights
- Aug 13th, 2026 5:04 pm
CapsoVision Reports Second Quarter 2026 Financial Results
- Aug 13th, 2026 2:05 pm
CapsoVision® Announces International Launch of AI Highlights
- Aug 3rd, 2026 2:30 pm
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
- Jul 30th, 2026 2:05 pm
Visteon Announces Second Quarter 2026 Financial Results and $200 Million Accelerated Share Repurchase Program
- Jul 23rd, 2026 4:55 am
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
- Jul 2nd, 2026 2:05 pm
CapsoVision Q1 Earnings Call Highlights
- May 14th, 2026 5:10 pm
CapsoVision Reports First Quarter 2026 Financial Results
- May 14th, 2026 2:05 pm
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026
- Apr 30th, 2026 2:05 pm
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership
- Apr 24th, 2026 11:35 am
CapsoVision Q4 Earnings Call Highlights
- Mar 26th, 2026 3:48 pm
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
- Mar 26th, 2026 2:05 pm
CapsoVision Announces $14 Million Private Placement Financing
- Mar 20th, 2026 6:00 am
CapsoVision to Participate in the 38th Annual ROTH Conference
- Mar 9th, 2026 2:05 pm
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans?
- Feb 16th, 2026 4:48 am
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
- Jan 2nd, 2026 10:10 am
Scroll